Inactive Instrument

News Arch Therapeutics Inc OTC Bulletin Board

Stocks

Medical Equipment, Supplies & Distribution

All News

Dec. 30	Arch Therapeutics, Inc. Went Out of Business	CI
Dec. 09	Modified Second Amended Liquidation Plan Approved for Arch Therapeutics, Inc.	CI
25-09-09	Second Amended Liquidation Plan and Disclosure Statement Filed by Arch Therapeutics, Inc.	CI
25-08-27	First Amended Liquidation Plan and Disclosure Statement Filed by Arch Therapeutics, Inc.	CI
25-07-10	Amended Disclosure Statement Filed by Arch Therapeutics, Inc.	CI
25-07-10	Liquidation Plan and Disclosure Statement Filed by Arch Therapeutics, Inc.	CI
25-06-25	Motion for Asset Sale Approved for Arch Therapeutics, Inc.	CI
25-05-27	Final DIP Financing Approved for Arch Therapeutics, Inc.	CI
25-05-27	Notice of Intent to Sale Filed by Arch Therapeutics, Inc.	CI
25-05-27	Bidding Procedure Approved for Arch Therapeutics, Inc.	CI
25-05-15	Motion for Asset Sale Filed by Arch Therapeutics, Inc.	CI
25-05-02	Interim DIP Financing Approved for Arch Therapeutics, Inc.	CI
25-04-21	Motion for Joint Administration Approved for Arch Therapeutics, Inc.	CI
25-04-18	Motion for Joint Administration Filed by Arch Therapeutics, Inc.	CI
25-04-18	Arch Therapeutics, Inc. Filed for Bankruptcy	CI
25-02-07	Arch Therapeutics, Inc. Announces Resignation of Michael S. Abrams from CFO	CI
25-02-07	Arch Therapeutics, Inc. Appoints Terrence W. Norchi, to the Roles of Principal Accounting Officer	CI
24-11-07	Arch Therapeutics : Material Agreement Form 8 K	PU
24-10-01	Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)	AQ
24-09-09	Arch Therapeutics, Inc. announces tranche update	CI
24-08-30	Arch Therapeutics, Inc. Announces Resignation of Laurence Hicks as Board Member	CI
24-08-19	Arch Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2024	CI
24-08-16	Arch Therapeutics, Inc. Announces Resignation of Punit Dhillon as Board Member	CI
24-07-28	Arch Therapeutics, Inc. announces tranche update	CI
24-06-29	Arch Therapeutics, Inc. announced that it has received $5.058 million in funding from Drake Partners, LLC, Oasis Capital, LLC	CI